Hans Lee
0000-0001-8545-3292
5 papers found
Refreshing results…
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis
Missing publications? Search for publications with a matching author name.